Metabolic effects of hormone deprivation therapy: weighing the evidence

Oncology (Williston Park). 2010 Aug;24(9):846-7.

Authors

G J Van Londen¹, Barry C Lembersky

Affiliation

¹ Department of Medicine (Geriatric Medicine, Hematology/Oncology), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

PMID: 20923042

No abstract available

Publication types

Comment

MeSH terms

Aged
Androgen Antagonists / adverse effects
Androgen Antagonists / therapeutic use
Aromatase Inhibitors / adverse effects
Aromatase Inhibitors / therapeutic use
Breast Neoplasms* / epidemiology
Breast Neoplasms* / pathology
Breast Neoplasms* / therapy
Decision Making
Disease Management
Female
Hormone Antagonists* / adverse effects
Hormone Antagonists* / therapeutic use
Humans
Male
Middle Aged
Neoplasm Metastasis
Prostatic Neoplasms* / epidemiology
Prostatic Neoplasms* / pathology
Prostatic Neoplasms* / therapy
Risk Assessment
Tamoxifen / adverse effects
Tamoxifen / therapeutic use

Substances

Androgen Antagonists
Aromatase Inhibitors
Hormone Antagonists
Tamoxifen